Your Web News in One Place

Help Webnuz

Referal links:

Sign up for GreenGeeks web hosting
June 26, 2019 02:41 pm PDT

Insulin: why the price of a 100-year-old drug has tripled in a decade

Insulin prices have skyrocketed to the point where many people with diabetes live in insulin poverty, with one in four rationing their insulin and an even larger proportion trading off other life necessities (food, rent, clothing) to afford their insulin supply.

The rise in insulin prices has nothing to do with recouping R&D costs (the majority of which are funded by government agencies, in any event): the cost of Humalog has risen 1000% in a decade, without any reformulations or refinements.

Why are the prices so high? Because there's no competition to speak of. Re-patenting and legal saber-rattling have kept most new entrants out of the market, while lax antitrust enforcement has allowed existing companies to merge, eliminating potential competitors.

Elizabeth Warren has made federal manufacture of generic drugs a campaign plank, with an emphasis on producing generic insulin.

Insulin prices have been rising for years, with lethal consequences. The effects of being unable to afford lifesaving medicine are weird, too: from forming insulin caravans to Canada to making DIY small-batch insulin of your own. Trump's insulin czar, meanwhile, is the Eli Lily president who oversaw a tripling in the price of insulin.

For Alec, that price was already steep: Even with his promotion, he was making $35,000 a year with no benefits. He and Smith-Holt had combed through Minnesotas Obamacare marketplace for months in search of a decent plan, but the affordable ones all had sky-high deductibles. That meant that hed be paying full price for his insulin for months before his junk insurance kicked in, on top of hundreds of dollars in monthly premiumssucking up some 80 percent of his take-home pay once he paid the rent.

Read the rest


Original Link: http://feeds.boingboing.net/~r/boingboing/iBag/~3/Ydc1Ci49Np4/pancreatic-cancers.html

Share this article:    Share on Facebook
View Full Article